We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Allscripts' (MDRX) dbMotion Solution Available Through Azure
Read MoreHide Full Article
Renowned information technology and service provider to healthcare organizations, Allscripts Healthcare Solutions, Inc. (MDRX - Free Report) , announced that dbMotion Solution will be now available through Microsoft Corporation’s (MSFT - Free Report) cloud computing service Azure. Notably, dbMotion Solution is Allscripts’ proprietary Community interoperability platform.
Stock Performance
A glimpse of the company’s price trend reveals that the stock has had an impressive run on the bourse year to date. Allscripts added 21.8%, comparing favorably with the Zacks classified Medical Info Systems sub-industry’s gain of 17.9%. Also, the current level compares favorably with the S&P 500’s return of 6.2% over the same time frame.
Despite the bullish price trend, estimate revision for the stock has been dismal. The full year saw seven analysts move south over the last one month, with one movement in the opposite direction. As a result, the Zacks Consensus Estimate for the full year dropped 6% to 47 cents over the same time frame. Notably, the stock has Zacks Rank #4 (Sell).
Coming back to the news, we feel Allscripts Healthcare move toward the cloud computing service Azure is prudent. With this move, dbMotion Solution will witness faster implementation of interoperability service and lower annual upgrade cost helping organizations to leverage the technology with less dependence on internal IT resources. Allscripts will also offer its proprietary Population Health Analytics solution (PHA), powered by dbMotion, via Azure.
Allscripts dbMotion integrates discrete real-time patient data from diverse care settings and health information technology systems into a single patient record and provider workflow, at the point of care. Such synchronized information across the entire system enables providers to easily access and manage information within familiar workflows, facilitate better care and disease management and move a step closer toward new payment models.
Allscripts Healthcare is a leading provider of healthcare information technology solutions. Looking forward, Allscripts’ management is focused on various restructuring initiatives such as streamlining operational efficiency, increasing R&D and catering to client needs. We believe favorable demographic trends, reinforced by a supportive regulatory environment, are expected to sustain growth in demand for its services.
Higher client demand for the company’s population health management solutions by healthcare systems, hospitals and ambulatory markets should also drive growth over the long haul.
Hologic has a long-term expected earnings growth rate of 11.33%. The stock has a stellar one-year return of roughly 21.3%.
Sunshine Heart delivered a positive earnings surprise of 58.24% in the last reported quarter. The company has a stellar EPS growth record (last 3–5 years of actual earnings) of almost 22%.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Allscripts' (MDRX) dbMotion Solution Available Through Azure
Renowned information technology and service provider to healthcare organizations, Allscripts Healthcare Solutions, Inc. (MDRX - Free Report) , announced that dbMotion Solution will be now available through Microsoft Corporation’s (MSFT - Free Report) cloud computing service Azure. Notably, dbMotion Solution is Allscripts’ proprietary Community interoperability platform.
Stock Performance
A glimpse of the company’s price trend reveals that the stock has had an impressive run on the bourse year to date. Allscripts added 21.8%, comparing favorably with the Zacks classified Medical Info Systems sub-industry’s gain of 17.9%. Also, the current level compares favorably with the S&P 500’s return of 6.2% over the same time frame.
Despite the bullish price trend, estimate revision for the stock has been dismal. The full year saw seven analysts move south over the last one month, with one movement in the opposite direction. As a result, the Zacks Consensus Estimate for the full year dropped 6% to 47 cents over the same time frame. Notably, the stock has Zacks Rank #4 (Sell).
Coming back to the news, we feel Allscripts Healthcare move toward the cloud computing service Azure is prudent. With this move, dbMotion Solution will witness faster implementation of interoperability service and lower annual upgrade cost helping organizations to leverage the technology with less dependence on internal IT resources. Allscripts will also offer its proprietary Population Health Analytics solution (PHA), powered by dbMotion, via Azure.
Allscripts dbMotion integrates discrete real-time patient data from diverse care settings and health information technology systems into a single patient record and provider workflow, at the point of care. Such synchronized information across the entire system enables providers to easily access and manage information within familiar workflows, facilitate better care and disease management and move a step closer toward new payment models.
Allscripts Healthcare is a leading provider of healthcare information technology solutions. Looking forward, Allscripts’ management is focused on various restructuring initiatives such as streamlining operational efficiency, increasing R&D and catering to client needs. We believe favorable demographic trends, reinforced by a supportive regulatory environment, are expected to sustain growth in demand for its services.
Higher client demand for the company’s population health management solutions by healthcare systems, hospitals and ambulatory markets should also drive growth over the long haul.
Key Picks
Better-ranked stocks in the broader medical sector include Hologic, Inc. (HOLX - Free Report) and Sunshine Heart Inc . Both stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Hologic has a long-term expected earnings growth rate of 11.33%. The stock has a stellar one-year return of roughly 21.3%.
Sunshine Heart delivered a positive earnings surprise of 58.24% in the last reported quarter. The company has a stellar EPS growth record (last 3–5 years of actual earnings) of almost 22%.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>